Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic and Clinical Evaluation of Medium-Chain Triglyceride-Based Exogenous Ketone Supplementation as an Adjunctive Treatment for First-Episode Psychosis

NCT07122531 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT07122531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07122531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic and Clinical Evaluation of Medium-Chain Triglyceride-Based Exogenous Ketone Supplementation as an Adjunctive Treatment for First-Episode Psychosis
Lead sponsor
Université de Sherbrooke
Phase
Not applicable
Overall status
Recruiting
Start date
August 26, 2025
Completion date
August 15, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

first episode psychosis